CH3 BioSystems
cart Cart (0 items)        



CH3 BioSystems was recognized in September 2012 by FROST & SULLIVAN with the presentation of the:

ENABLING TECHNOLOGY AWARD for CHEMICAL BIOLOGY & EPIGENETICS NORTH AMERICA 2012

CH3 BioSystems is also prominently featured in the Markets and Markets Report on the Epigenetics Technology Market


 
Get the latest news in protein methylation research & CH3 BioSystems. more

New Product!
UNIQUE High Activity PRMT7, Type III
Methyltransferase
NOW AVAILABLE
ONLY from
CH3 BioSystems


CH3 BioSystems is a biotechnology company based on an entirely new patent-protected chemical technology designed to identify and commercialize drug and diagnostic candidates.

We manufacture novel molecular tools to help biomedical research better understand cancer and autoimmune, neurodevelopmental, viral and cardiovascular diseases that affect millions of people around the world.

Our long-range vision is to facilitate the creation of diagnostic and pharmaceutical products that are based on the emerging new field of protein methylation biology.

  
University Commons • 1416 Sweet Home Rd, Suite 3 • Amherst, NY 14228
tel. 716.688.5222 • fax. 866.610.2261 • info@ch3biosystems.com
Copyright © CH3 BioSystems, LLC 2007-2009